Proxy Votes Now

Home › Activist investors › Engaged Capital

Engaged Capital

Campaign activist. Positions and campaigns from Engaged Capital’s SEC filings. Updated November 20, 2026.

Filer entities
Engaged Capital LLC
SEC CIK
1559771 (Engaged Capital LLC)
SEC filings
Schedule 13D filings · 13F reports · soliciting material
Latest 13F
Quarter ended Sep 30, 2026, filed Nov 16, 2026: 8 US-listed positions reported; 4 of 1% or more of a company without a 13D are listed below.
5current positions
4new or changed in 90 days; 2 exited
0active campaigns
23campaigns on record

Active campaigns

No active campaign by this definition (see How to read this).

Current positions (5)

CompanyStakeSourceFirst disclosedLast changeSince previous filingFlagsStated intent
Evolent Health, Inc. 4.45%5,032,806 shares 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Oct 30, 2026 Nov 16, 2020 Decreased Nov 16, 2026 ▼ 0.47 pts Decreased 13F: none stated
YETI Holdings, Inc. 2.35%1,714,095 shares 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Aug 6, 2026 May 15, 2025 Increased Nov 16, 2026 ▲ 0.71 pts Increased 13F: none stated
Portillo'S Inc. 2.09%1,507,990 shares 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Mar 29, 2026 May 15, 2024 Decreased Nov 16, 2026 ▼ 2.68 pts Decreased 13F: none stated
VF Corporation 1.43%5,618,894 shares 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Oct 24, 2026 Nov 14, 2023 Increased Nov 16, 2026 ▲ 0.28 pts Increased 13F: none stated
BRC Inc. 12.7%14,597,791 shares Schedule 13D/A, filed Jan 21, 2026 Jul 3, 2023 Increased Jan 21, 2026 ▼ 0.10 pts — Standard Item 4 language

Stake: the latest 13D’s percent of the class (the largest single reporting person’s, as filed), or for a 13F the reported shares as a percent of the company’s shares outstanding on the date shown. Since previous filing: the change in percentage points against the investor’s previous 13D on the company, or its previous 13F.

Stated intent (13D Item 4)

Item 4 of a Schedule 13D (“Purpose of Transaction”) is where the investor states its plans. The label is a plain reading of that text; the excerpt is quoted from the filing.

BRC Inc. · Standard Item 4 language

“Item 4 is hereby amended to add the following: On July 18, 2025, Engaged Capital Flagship Master purchased 400,000 Shares in the Issuer's underwritten public offering (the "Offering") at the public offering price of $1.25 per Share. In connection with the Offering, Engaged Capital Flagship Master entered into a customary lock-up agreement with the underwriter (the "Lock-Up Agreement"), pursuant to”

Item 4 in the Schedule 13D/A filed Jan 21, 2026; this amendment did not restate Item 4, so the text is from the filing of Jul 22, 2025.

Campaigns are compiled from SEC filings (13D, proxy contest filings and settlement 8-Ks); campaigns run without SEC filings, e.g. by public letter below the 5% threshold, may not appear.

Past campaigns (23)
CompanyOutcome or last statusDateFirst filingHighest stageFilingsMeeting / votes
Blackline, Inc. Settled (agreement with the company) Mar 10, 2026 Jan 13, 2026 Soliciting material filed latest (8) —
Portillo's Inc.Board seats Stake reported below 5% Oct 22, 2025 Aug 15, 2024 Nominations made latest (8) —
YETI Holdings, Inc.Board seats Settled — 2 board seats Mar 17, 2025 Mar 17, 2025 — latest (1) —
Evolent Health, Inc. Settled (agreement with the company) Dec 22, 2020 Aug 20, 2020 — latest (3) —
Nevro Corp Stake reported below 5% Nov 14, 2024 Dec 11, 2023 — latest (4) —
Quotient Technology Inc.Board seats Stake reported below 5% Jul 7, 2023 Nov 17, 2021 Proxy contest filed (preliminary proxy) latest (7) —
Shake Shack Inc. Settled (agreement with the company) May 16, 2023 May 16, 2023 — latest (1) —
Upbound Group, Inc.Board seats Settled (agreement with the company) Feb 7, 2018 Jan 30, 2017 Proxy contest filed latest (21) —
New Relic, Inc. Settled (agreement with the company) Jun 25, 2021 Jun 25, 2021 — latest (1) —
OneSpan Inc. Settled (agreement with the company) May 20, 2021 May 20, 2021 — latest (1) —
Medifast Inc Settled (agreement with the company) Apr 6, 2015 May 14, 2014 — latest (3) —
Apogee Enterprises, Inc. Settled (agreement with the company) Nov 12, 2019 Apr 17, 2018 — latest (2) —
Innerworkings Inc Settled (agreement with the company) Aug 9, 2019 Aug 9, 2019 — latest (1) —
Del Frisco's Restaurant Group, Inc. Settled (agreement with the company) Feb 4, 2019 Dec 6, 2018 — latest (3) —
Benchmark Electronics IncBoard seats Settled (agreement with the company) Dec 21, 2016 Feb 26, 2016 Proxy contest filed latest (21) —
Aratana Therapeutics, Inc.Board seats Settled — 3 board seats May 21, 2018 Apr 5, 2018 — latest (2) —
Hain Celestial Group Inc Settled (agreement with the company) Sep 28, 2017 Jun 29, 2017 — latest (2) —
Outerwall Inc Settled (agreement with the company) Apr 12, 2016 Feb 8, 2016 — latest (3) —
HeartWare International, Inc.Board seats Settled (agreement with the company) Jan 28, 2016 Dec 31, 2015 Proxy contest filed (preliminary proxy) latest (4) —
Rovi CorpBoard seats No campaign filings in the last 12 months May 8, 2015 Mar 12, 2015 Proxy contest filed latest (13) —
Trimas Corp Settled (agreement with the company) Feb 25, 2015 Feb 25, 2015 — latest (1) —
Oplink Communications IncBoard seats No campaign filings in the last 12 months Nov 6, 2014 Jul 14, 2014 Proxy contest filed (preliminary proxy) latest (6) —
Rentech Inc /Co/ No campaign filings in the last 12 months Mar 27, 2014 Jan 13, 2014 Soliciting material filed latest (8) —
Past positions (6)
CompanyLast stakeSourceOutcomeDate
BlackLine, Inc. 1.42% 13F, quarter ended Jun 30, 2026filed Aug 14, 2026; % of shares outstanding as of Jul 31, 2026 Not in the latest 13F Nov 16, 2026
Freshpet, Inc. 1.01% 13F, quarter ended Jun 30, 2026filed Aug 14, 2026; % of shares outstanding as of Jul 31, 2026 Not in the latest 13F Nov 16, 2026
Nevro Corp 1.5% Schedule 13D/A, filed Nov 14, 2024 Reported below 5% in a 13D/A Nov 14, 2024
Upbound Group, Inc. — Schedule 13D/A, filed Dec 13, 2023stake not read from this filing’s format: see the filing Not in the 13F for the quarter ended Sep 30, 2024 Nov 14, 2024
Pra Group Inc 5.0% Schedule 13D/A, filed Feb 16, 2024 Reported below 5% in a 13D/A Feb 16, 2024
Quotient Technology Inc. 5.0% Schedule 13D/A, filed Jul 7, 2023 Reported below 5% in a 13D/A Jul 7, 2023

How large managers voted in Engaged Capital’s proxy contests (meetings since July 2023)

Fund votes come from Form N-PX filings, which this site holds from July 1, 2023 (meetings through June 30, 2026; later meetings appear when the managers file their next N-PX); earlier contests and campaigns that settled before a vote are listed under the activist’s campaigns.

No proxy contest has gone to a vote since July 1, 2023.

Track record

How each campaign on record ended, as read from the filings: settlements disclosed in the company’s 8-K or the investor’s 13D, contested votes (8-K Item 5.07), withdrawals and 13D amendments below 5%.

2Settlement with board seats
18Settlement
3No outcome in the filings read
5board seats from settlements and contest votes
Outcome of each campaign (23)
CompanyOutcomeDetailDateFirst filing
Blackline, Inc. Settlement agreement with the company Mar 10, 2026 Jan 13, 2026
Portillo's Inc. Settlement agreement with the company Apr 28, 2025 Aug 15, 2024
YETI Holdings, Inc. Settlement with board seats 2 board seats Mar 17, 2025 Mar 17, 2025
Evolent Health, Inc. Settlement agreement with the company Feb 4, 2025 Aug 20, 2020
Nevro Corp Settlement agreement with the company Feb 21, 2024 Dec 11, 2023
Quotient Technology Inc. Settlement agreement with the company Jun 6, 2023 Nov 17, 2021
Shake Shack Inc. Settlement agreement with the company May 16, 2023 May 16, 2023
Upbound Group, Inc. Settlement agreement with the company May 29, 2018 Jan 30, 2017
New Relic, Inc. Settlement agreement with the company Jun 25, 2021 Jun 25, 2021
OneSpan Inc. Settlement agreement with the company May 20, 2021 May 20, 2021
Medifast Inc Settlement agreement with the company Apr 6, 2015 May 14, 2014
Apogee Enterprises, Inc. Settlement agreement with the company Nov 12, 2019 Apr 17, 2018
Innerworkings Inc Settlement agreement with the company Aug 9, 2019 Aug 9, 2019
Del Frisco's Restaurant Group, Inc. Settlement agreement with the company Aug 5, 2019 Dec 6, 2018
Benchmark Electronics Inc Settlement agreement with the company Feb 26, 2019 Feb 26, 2016
Aratana Therapeutics, Inc. Settlement with board seats 3 board seats May 21, 2018 Apr 5, 2018
Hain Celestial Group Inc Settlement agreement with the company Sep 28, 2017 Jun 29, 2017
Outerwall Inc Settlement agreement with the company Aug 5, 2016 Feb 8, 2016
HeartWare International, Inc. Settlement agreement with the company Jan 28, 2016 Dec 31, 2015
Rovi Corp No outcome in the filings read — May 8, 2015 Mar 12, 2015
Trimas Corp Settlement agreement with the company Feb 25, 2015 Feb 25, 2015
Oplink Communications Inc No outcome in the filings read — Nov 6, 2014 Jul 14, 2014
Rentech Inc /Co/ No outcome in the filings read — Mar 27, 2014 Jan 13, 2014

Share price after the first 13D

The change in the company’s closing share price from the first trading day on or before the investor’s first Schedule 13D to the latest close, and to 6 and 12 months after it, beside the S&P 500 (SPY) over the same dates. This is a price change after a filing date: it is not attributed to the investor, and it is not the investor’s return. Coverage: 0 of 5 13D positions have prices (the site’s daily price history starts November 10, 2025, and covers only listed tickers it tracks).

Settlement terms

Terms of the cooperation agreements, read by rules from the company’s Form 8-K (or the investor’s 13D where it describes the agreement). Each term is quoted from the filing; terms a rule did not find are not listed, so a missing term is not evidence that the agreement lacks it.

Blackline, Inc. · Mar 10, 2026 · Committee role
Portillo's Inc. · Apr 28, 2025 · Voting commitment
YETI Holdings, Inc. · Mar 17, 2025 · Ownership cap, Board seats, Voting commitment
Evolent Health, Inc. · Feb 4, 2025 · Directors named, Ownership cap, Voting commitment
Nevro Corp · Feb 21, 2024 · Directors named, Ownership cap
Shake Shack Inc. · May 16, 2023 · Directors named
Quotient Technology Inc. · May 18, 2022 · Directors named
New Relic, Inc. · Jun 25, 2021 · Directors named
OneSpan Inc. · May 20, 2021 · Directors named
Apogee Enterprises, Inc. · Nov 12, 2019 · Ownership cap, Voting commitment
Innerworkings Inc · Aug 9, 2019 · Directors named, Ownership cap, Committee role, Voting commitment
Benchmark Electronics Inc · Feb 26, 2019 · Voting commitment
Del Frisco's Restaurant Group, Inc. · Feb 4, 2019 · Directors named, Voting commitment
Aratana Therapeutics, Inc. · May 21, 2018 · Ownership cap, Board seats, Voting commitment
Upbound Group, Inc. · Feb 7, 2018 · Voting commitment
Outerwall Inc · Apr 12, 2016 · Directors named, Voting commitment
Medifast Inc · Apr 6, 2015 · Committee role, Standstill, Voting commitment
Trimas Corp · Feb 25, 2015 · Directors named

Other disclosed holders around the same time

Filings by other activists on this list (their first 13D or 13F on the company) and by other holders of 5% or more (Schedule 13D or 13G) dated within 180 days of Engaged Capital’s first disclosure in the same company. They are listed together by date only; nothing here says the holders act together.

YETI Holdings, Inc. · Engaged Capital first disclosed May 15, 2025 · 5 other filings
HolderFormDateStake
Baillie Gifford & Co Schedule 13G Feb 12, 2025 9.1%
BlackRock, Inc. Schedule 13G Apr 24, 2025 9.1%
Wellington Management Group LLP Schedule 13G Aug 12, 2025 5.9%
Wasatch Advisors LP Schedule 13G Aug 14, 2025 2.3%
The Vanguard Group Schedule 13G Sep 8, 2025 10.3%
BlackLine, Inc. · Engaged Capital first disclosed Nov 14, 2024 · 1 other filing
HolderFormDateStake
FMR LLC Schedule 13G May 12, 2025 6.1%
Quotient Technology Inc. · Engaged Capital first disclosed Jun 6, 2023 · 1 other filing
HolderFormDateStake
Magnetar Financial LLC Schedule 13D Jul 20, 2023 5.4%

How to read this

Flags (last 90 days)
New first disclosed in the last 90 days. Increased / Decreased shares up or down in a 13D/A or 13F filed in that time. Below 5% a 13D/A reported less than 5%, the reporting threshold. Exited a 13D/A reported no shares, or the investor’s 13F no longer lists a company it listed before.
Active campaign
A contested meeting at which the investor is soliciting proxies is still to be held; or in the last 12 months it filed a proxy-contest document (PREC14A, DEFC14A or DFAN14A soliciting material), stated in a 13D that it nominated directors, filed a letter or presentation to the board or shareholders, or stated public demands in a 13D — and no settlement, withdrawal, contested vote or 13D below 5% is dated on or after the latest such filing. Status is the furthest step since then: Public demands in a 13D < Public letter or soliciting material < Nominations made < Proxy contest filed.
Sources and limits
SEC EDGAR only. 13D data covers filings since June 2023; 13F reports are quarterly and filed up to 45 days after the quarter, and do not show swaps, most options or non-US holdings. Settlements are cooperation agreements disclosed in the company’s 8-K or stated in the investor’s 13D; board seats are read from the 8-K. Text marked Summary of the filing is checked against the filing, whose words are quoted beside it. Nothing on this page predicts what the investor will do.